CO6190613A2 - Formas cristalinas de glyt1 - Google Patents
Formas cristalinas de glyt1Info
- Publication number
- CO6190613A2 CO6190613A2 CO09061117A CO09061117A CO6190613A2 CO 6190613 A2 CO6190613 A2 CO 6190613A2 CO 09061117 A CO09061117 A CO 09061117A CO 09061117 A CO09061117 A CO 09061117A CO 6190613 A2 CO6190613 A2 CO 6190613A2
- Authority
- CO
- Colombia
- Prior art keywords
- trifluor
- methanone
- fluor
- piperazin
- methanesulfonyl
- Prior art date
Links
- 102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 title 1
- 101000972916 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 title 1
- 239000011521 glass Substances 0.000 title 1
- YUUGYIUSCYNSQR-LBPRGKRZSA-N [4-[3-fluoro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-[5-methylsulfonyl-2-[(2s)-1,1,1-trifluoropropan-2-yl]oxyphenyl]methanone Chemical compound FC(F)(F)[C@H](C)OC1=CC=C(S(C)(=O)=O)C=C1C(=O)N1CCN(C=2C(=CC(=CN=2)C(F)(F)F)F)CC1 YUUGYIUSCYNSQR-LBPRGKRZSA-N 0.000 abstract 5
- 238000002441 X-ray diffraction Methods 0.000 abstract 4
- 229910016523 CuKa Inorganic materials 0.000 abstract 3
- 230000005855 radiation Effects 0.000 abstract 3
- 238000002329 infrared spectrum Methods 0.000 abstract 2
- -1 3-fluor-5-tri-fluoromethyl-pyridin-2-yl Chemical group 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06127269 | 2006-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6190613A2 true CO6190613A2 (es) | 2010-08-19 |
Family
ID=38988312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09061117A CO6190613A2 (es) | 2006-12-28 | 2009-06-11 | Formas cristalinas de glyt1 |
Country Status (33)
| Country | Link |
|---|---|
| US (5) | US20080214561A1 (OSRAM) |
| EP (1) | EP2114405B1 (OSRAM) |
| JP (1) | JP4799666B2 (OSRAM) |
| KR (1) | KR101130146B1 (OSRAM) |
| CN (1) | CN101573114A (OSRAM) |
| AR (1) | AR064545A1 (OSRAM) |
| AU (1) | AU2007341356B2 (OSRAM) |
| BR (1) | BRPI0720829B8 (OSRAM) |
| CA (1) | CA2673667A1 (OSRAM) |
| CL (1) | CL2007003830A1 (OSRAM) |
| CO (1) | CO6190613A2 (OSRAM) |
| CR (1) | CR10846A (OSRAM) |
| CY (1) | CY1116350T1 (OSRAM) |
| DK (1) | DK2114405T3 (OSRAM) |
| EC (1) | ECSP099471A (OSRAM) |
| ES (1) | ES2535040T3 (OSRAM) |
| HR (1) | HRP20150573T1 (OSRAM) |
| HU (1) | HUE025032T2 (OSRAM) |
| MA (1) | MA31029B1 (OSRAM) |
| MX (1) | MX2009006859A (OSRAM) |
| MY (1) | MY188367A (OSRAM) |
| NO (1) | NO342150B1 (OSRAM) |
| NZ (1) | NZ577502A (OSRAM) |
| PE (1) | PE20081556A1 (OSRAM) |
| PL (1) | PL2114405T3 (OSRAM) |
| PT (1) | PT2114405E (OSRAM) |
| RS (1) | RS53910B1 (OSRAM) |
| RU (1) | RU2463295C2 (OSRAM) |
| SI (1) | SI2114405T1 (OSRAM) |
| TW (1) | TWI388552B (OSRAM) |
| UA (1) | UA100232C2 (OSRAM) |
| WO (1) | WO2008080821A1 (OSRAM) |
| ZA (1) | ZA200904423B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101573114A (zh) | 2006-12-28 | 2009-11-04 | 弗·哈夫曼-拉罗切有限公司 | 结晶形式glyt1 |
| WO2010099323A1 (en) * | 2009-02-26 | 2010-09-02 | Thar Pharmaceuticals, Inc. | Crystalization of pharmaceutical compounds |
| KR101196354B1 (ko) * | 2010-09-03 | 2012-11-01 | 서유헌 | 퇴행성 신경계 뇌 질환의 예방 또는 치료용 약학 조성물 |
| EA201401312A1 (ru) * | 2012-05-25 | 2015-09-30 | Басф Се | КРИСТАЛЛИЧЕСКАЯ ФОРМА В 1,5-ДИМЕТИЛ-6-ТИОКСО-3-(2,2,7-ТРИФТОР-3-ОКСО-4-(ПРОП-2-ИНИЛ)-3,4-ДИГИДРО-2Н-БЕНЗО[b][1,4]ОКСАЗИН-6-ИЛ)-1,3,5-ТРИАЗИНАН-2,4-ДИОНА |
| US8927412B1 (en) * | 2013-08-01 | 2015-01-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Multi-chip package and method of formation |
| MX354615B (es) * | 2013-10-02 | 2018-03-08 | Centro De Investig Y De Estudios Avanzados Del I P N | Uso del propilparabeno comoagente neuroprotector en el daño neuronal inducido por status epilepticus. |
| CA3166938A1 (en) | 2020-01-09 | 2021-07-15 | Disc Medicine, Inc. | Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors |
| WO2022014396A1 (ja) * | 2020-07-13 | 2022-01-20 | 日本碍子株式会社 | 精製方法 |
| JP2024518091A (ja) * | 2021-05-14 | 2024-04-24 | ディスク・メディシン・インコーポレイテッド | グリシン輸送阻害剤を用いて赤血球増殖性プロトポルフィリン症、ｘ連鎖プロトポルフィリン症または先天性赤血球増殖性ポルフィリン症を処置する方法 |
| JP2024520391A (ja) * | 2021-05-27 | 2024-05-24 | ディスク・メディシン・インコーポレイテッド | ビトペルチンの固体形態を用いて赤血球増殖性プロトポルフィリン症、ｘ連鎖プロトポルフィリン症または先天性赤血球増殖性ポルフィリン症を処置する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL154370A0 (en) | 2003-02-10 | 2003-09-17 | Chemagis Ltd | Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same |
| RS53252B (sr) * | 2003-08-11 | 2014-08-29 | F.Hoffmann-La Roche Ag. | Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1 |
| CN101573114A (zh) | 2006-12-28 | 2009-11-04 | 弗·哈夫曼-拉罗切有限公司 | 结晶形式glyt1 |
-
2007
- 2007-12-18 CN CNA2007800479512A patent/CN101573114A/zh active Pending
- 2007-12-18 RS RS20150229A patent/RS53910B1/sr unknown
- 2007-12-18 SI SI200731644T patent/SI2114405T1/sl unknown
- 2007-12-18 EP EP07857734.3A patent/EP2114405B1/en active Active
- 2007-12-18 DK DK07857734T patent/DK2114405T3/en active
- 2007-12-18 NZ NZ577502A patent/NZ577502A/en unknown
- 2007-12-18 KR KR1020097015643A patent/KR101130146B1/ko active Active
- 2007-12-18 BR BRPI0720829A patent/BRPI0720829B8/pt active IP Right Grant
- 2007-12-18 PL PL07857734T patent/PL2114405T3/pl unknown
- 2007-12-18 UA UAA200907731A patent/UA100232C2/uk unknown
- 2007-12-18 HU HUE07857734A patent/HUE025032T2/en unknown
- 2007-12-18 MX MX2009006859A patent/MX2009006859A/es active IP Right Grant
- 2007-12-18 WO PCT/EP2007/064104 patent/WO2008080821A1/en not_active Ceased
- 2007-12-18 ES ES07857734.3T patent/ES2535040T3/es active Active
- 2007-12-18 CA CA002673667A patent/CA2673667A1/en not_active Abandoned
- 2007-12-18 PT PT78577343T patent/PT2114405E/pt unknown
- 2007-12-18 AU AU2007341356A patent/AU2007341356B2/en active Active
- 2007-12-18 MY MYPI20092584A patent/MY188367A/en unknown
- 2007-12-18 JP JP2009543441A patent/JP4799666B2/ja active Active
- 2007-12-18 HR HRP20150573TT patent/HRP20150573T1/hr unknown
- 2007-12-18 RU RU2009124113/04A patent/RU2463295C2/ru active
- 2007-12-19 US US12/002,997 patent/US20080214561A1/en not_active Abandoned
- 2007-12-25 TW TW096150002A patent/TWI388552B/zh active
- 2007-12-27 CL CL200703830A patent/CL2007003830A1/es unknown
- 2007-12-27 AR ARP070105913A patent/AR064545A1/es not_active Application Discontinuation
-
2008
- 2008-01-02 PE PE2008000055A patent/PE20081556A1/es not_active Application Discontinuation
-
2009
- 2009-06-08 CR CR10846A patent/CR10846A/es unknown
- 2009-06-11 CO CO09061117A patent/CO6190613A2/es not_active Application Discontinuation
- 2009-06-19 NO NO20092358A patent/NO342150B1/no unknown
- 2009-06-24 ZA ZA200904423A patent/ZA200904423B/xx unknown
- 2009-06-26 EC EC2009009471A patent/ECSP099471A/es unknown
- 2009-06-29 MA MA32049A patent/MA31029B1/fr unknown
-
2010
- 2010-07-22 US US12/841,195 patent/US8039473B2/en not_active Expired - Fee Related
-
2011
- 2011-07-22 US US13/188,486 patent/US20110295007A1/en not_active Abandoned
-
2012
- 2012-06-13 US US13/495,093 patent/US20120309969A1/en not_active Abandoned
-
2013
- 2013-03-13 US US13/798,358 patent/US20130197225A1/en not_active Abandoned
-
2015
- 2015-05-20 CY CY20151100451T patent/CY1116350T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6190613A2 (es) | Formas cristalinas de glyt1 | |
| CA113992S (en) | Window component extrusion | |
| ES2530695T3 (es) | 4-[3-(4-ciclopropanocarbonil-piperazina-1-carbonil)-4-fluoro-bencil]-2H-ftalazin-1-ona | |
| BRPI0818591A2 (pt) | Processo para a produção de um capacitor eletrolítico, capacitor eletrolítico e uso de capacitores eletrolíticos | |
| IL200705A0 (en) | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design | |
| NO20081469L (no) | Fremgangsmåte for fremstilling, erstatning eller utvinning av gasshydrat | |
| EP1598441A4 (en) | AMORPHEMA CARBON FILM, MANUFACTURING METHOD DAF R AND MATERIAL COATED THEREFOR | |
| EP1898267A4 (en) | METHOD FOR PRODUCING A LIQUID DEVELOPER AND LIQUID DEVELOPER MADE IN THIS METHOD | |
| WO2011005440A3 (en) | Aggregate particles of titanium dioxide for solar cells | |
| JP2008520091A5 (OSRAM) | ||
| EP1970356A4 (en) | COMPOSITE GLASS WITH SHADOWBAND | |
| USD578665S1 (en) | Window component extrusion | |
| PT1348867E (pt) | Instalacao eolica de producao de electricidade, no mar, bem como processo de construcao e de mentagem de tal instalacao | |
| EP4009384A4 (en) | SOLAR CELL STRING, SOLAR CELL MODULE, SOLAR CELL SHEET AND METHOD OF MANUFACTURING THEREOF | |
| CN201137852Y (zh) | 一种太阳能幕墙灯 | |
| CN208756614U (zh) | 一种挂壁式具有臭氧发生器的紫外线灯 | |
| AU2003276273A1 (en) | Electrochemical generator with asymmetric pressure profile | |
| CN106803549A (zh) | 一种新型加强筋防膨胀电池外壳 | |
| DE602007009933D1 (de) | Normensatz und produktionsverfahren | |
| GB2422842B (en) | Process for the production of multipurpose energy sources and multipurpose energy sources produced by said process | |
| CA113586S (en) | Window component extrusion | |
| USD546774S1 (en) | Power production display for a generator | |
| CN204407385U (zh) | 一种新型18650电池组合结构 | |
| AU2002349559A1 (en) | Photo-catalyst pigment photo-catalyzed by visible light and the production process thereof | |
| EP1886297A4 (en) | METHOD FOR CONVERTING A FREQUENCY SPECTRUM IN NATURAL AND HARMONIOUS FREQUENCIES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |